Characterising the asynchronous resurgence of common respiratory viruses following the COVID-19 pandemic.

Characterising the asynchronous resurgence of common respiratory viruses following the COVID-19 pandemic.

Publication date: Feb 13, 2025

The COVID-19 pandemic and relevant non-pharmaceutical interventions (NPIs) interrupted the circulation of common respiratory viruses. These viruses demonstrated an unprecedented asynchronous resurgence as NPIs were relaxed. We compiled a global dataset from a systematic review, online surveillance reports and unpublished data from Respiratory Virus Global Epidemiology Network, encompassing 92 sites. We compared the resurgence timings of respiratory viruses within each site and synthesised differences in timings across sites, using a generalised linear mixed-effects model. We revealed a distinct sequential timing in the first post-pandemic resurgence: rhinovirus resurged the earliest, followed by seasonal coronavirus, parainfluenza virus, respiratory syncytial virus, adenovirus, metapneumovirus and influenza A virus, with influenza B virus exhibiting the latest resurgence. Similar sequential timing was observed in the second resurgence except influenza A virus caught up with metapneumovirus. The consistent asynchrony across geographical regions suggests that virus-specific characteristics, rather than location-specific factors, determining the relative timing of resurgence.

Open Access PDF

Concepts Keywords
Coronavirus Coronavirus
Latest COVID-19
Pandemic Humans
Pharmaceutical Influenza A virus
Relaxed Influenza B virus
Metapneumovirus
Pandemics
Respiratory Tract Infections
Rhinovirus
SARS-CoV-2

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease IDO site
disease MESH parainfluenza
drug DRUGBANK Influenza A virus
drug DRUGBANK Influenza B virus
disease MESH influenza
disease MESH data source
disease IDO quality
disease IDO country
disease IDO infectivity
disease IDO history
disease IDO host
disease MESH infection
disease IDO replication
disease IDO virulence
disease MESH respiratory infections
disease IDO process
disease IDO pathogen
drug DRUGBANK Esomeprazole
disease MESH Infectious Diseases
drug DRUGBANK Tretamine
drug DRUGBANK Fenamole
drug DRUGBANK Coenzyme M
disease MESH morbidity
disease MESH death
disease MESH viral infections
disease MESH pneumonia
disease MESH common cold
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Nandrolone phenpropionate
drug DRUGBANK 2-Amino-1-methyl-6-phenylimidazo(4 5-b)pyridine
drug DRUGBANK L-Aspartic Acid
disease MESH respiratory diseases
disease MESH weight loss
disease MESH lifestyle
disease IDO intervention
pathway REACTOME Reproduction
drug DRUGBANK Trestolone

Original Article

(Visited 1 times, 1 visits today)